Affinity of human IgG subclasses to mouse Fc gamma Receptors

Slides:



Advertisements
Similar presentations
Fc Receptors Oct. 28, 2009 Extra reading on web Daniel Conrad 423 MSB, I. CD23.
Advertisements

MLRS 242 Immunology Pat Reed Antibodies
8 th lecture The collaborations between innate and adaptive immunity. Antibody types and functions.
Volume 13, Pages (November 2016)
Fig. 1. Development of an anti-FcεRI Fab fragment antibody NPB311
Evaluation of SERS labeling of CD20 on CLL cells using optical microscopy and fluorescence flow cytometry  Christina M. MacLaughlin, BSc, Edward P.K.
IMMUNOGLOBULIN STRUCTURE AND FUNCTION
Eurofins BioPharma Product Testing Munich GmbH
Volume 13, Issue 11, Pages (December 2015)
THERAPEUTIC Monoclonal Antibodies:
Figure 1 Structure of TNF antagonists
ORF2S antigenically overlaps with virions and interferes with antibody-mediated neutralization but not entry of HEV. (A) Location of six distinct antigenic.
Pathways Responsible for Human Autoantibody and Therapeutic Intravenous IgG Activity in Humanized Mice  Inessa Schwab, Anja Lux, Falk Nimmerjahn  Cell.
A Naturally Occurring Mutation in FcγRIIA: A Q to K127 Change Confers Unique IgG Binding Properties to the R131 Allelic Form of the Receptor by Cynthia.
Volume 158, Issue 6, Pages (September 2014)
Figure 2 GlyR antibody binding
Nonhemolytic antigen loss from red blood cells requires cooperative binding of multiple antibodies recognizing different epitopes by James C. Zimring,
Volume 7, Issue 2, Pages (August 1997)
Red pulp macrophages in the human spleen are a distinct cell population with a unique expression of Fc-γ receptors by Sietse Q. Nagelkerke, Christine W.
Figure 2 Co-stimulatory receptors as immunomodulatory targets
No Need for Constant Help: Human IgG2 Antibodies Have an Autonomous Agonistic Activity for Immunotherapy of Cancer  Anja Lux, Falk Nimmerjahn  Cancer.
Anti-Inflammatory Activity of Human IgG4 Antibodies by Dynamic Fab Arm Exchange by Marijn van der Neut Kolfschoten, Janine Schuurman, Mario Losen, Wim.
Figure 4 Approaches to targeting inhibitory immune receptors
Development of Next-Generation Immunomodulatory Antibodies for Cancer Therapy through Optimization of the IgG Framework  Rienk Offringa, Martin J. Glennie 
Volume 45, Issue 3, Pages (February 2005)
Fcγ Receptors: Old Friends and New Family Members
Figure 2 Influence of fucosylation on IgG effector functions
Figure 2 Emerging models of antibody-mediated rejection (ABMR) and
Figure 3 Effect of sialylated glycoforms on IgG activity
Volume 28, Issue 3, Pages (September 2015)
Volume 91, Issue 6, Pages (December 1997)
Anti–4-1BB/PD-1 combination enhanced antigen-specific T-cell response.
The Interaction Properties of Costimulatory Molecules Revisited
CD169+ macrophages play a critical role in mediating innate immune cell reorganization. CD169+ macrophages play a critical role in mediating innate immune.
Identification of novel IgGs in alpaca serum.
Nat. Rev. Endocrinol. doi: /nrendo
Silvia Bolland, Roger N Pearse, Tomohiro Kurosaki, Jeffrey V Ravetch 
Figure 2 Binding of the patient's IgG to Purkinje cells is inhibited by pretreatment of rat tissue with anti-VGCC antibodies, confirming specificity of.
The MSP domain of MOSPD2 binds the FFAT motif with an affinity in the micromolar range The MSP domain of MOSPD2 binds the FFAT motif with an affinity in.
FcγRIV: A Novel FcR with Distinct IgG Subclass Specificity
SHIP Recruitment Attenuates FcγRIIB-Induced B Cell Apoptosis
Volume 18, Issue 8, Pages (August 2010)
Volume 11, Issue 19, Pages (October 2001)
Rapid desensitization of mice with anti-FcγRIIb/FcγRIII mAb safely prevents IgG- mediated anaphylaxis  Marat V. Khodoun, PhD, Zeynep Yesim Kucuk, MD, Richard.
Tom E. Williams, Shanmugam Nagarajan, Periasamy Selvaraj, Cheng Zhu 
Taia T. Wang, Jeffrey V. Ravetch  Immunity 
Volume 7, Issue 1, Pages (April 2014)
Structural Basis for Specific Recognition of Reelin by Its Receptors
CD44 binding surface of the Tiam2 PHCCEx domain.
TRADD–TRAF2 and TRADD–FADD Interactions Define Two Distinct TNF Receptor 1 Signal Transduction Pathways  Hailing Hsu, Hong-Bing Shu, Ming-Gui Pan, David.
Volume 16, Issue 3, Pages (March 2002)
Volume 6, Issue 1, Pages (July 2009)
Volume 29, Issue 6, Pages (June 2016)
Volume 84, Issue 1, Pages (January 2003)
Mutant Alanine Position
Michael S. Kuhns, Mark M. Davis  Immunity 
Arp2/3-mediated formation of nuclear actin networks is essential for CD4+ T cell effector functions. Arp2/3-mediated formation of nuclear actin networks.
SLE: the many players involved in systemic autoimmunity and tissue destruction. SLE: the many players involved in systemic autoimmunity and tissue destruction.
The Inhibitory Receptor LIR-1 Uses a Common Binding Interaction to Recognize Class I MHC Molecules and the Viral Homolog UL18  Tara L Chapman, Astrid.
Affinities of the SV9 specific bs-868Z11-CD3 bsTCR with different MHC monomers and peptide ligands. Affinities of the SV9 specific bs-868Z11-CD3 bsTCR.
Volume 8, Issue 2, Pages (February 1998)
BMS blocks functional responses in primary immune cells driven by IFNα
Volume 13, Issue 1, Pages (July 2000)
B7-1 and PD-1 compete for binding to PD-L1.
Elva Dı́az, Suzanne R Pfeffer  Cell 
by Kevin J. Paavola, Harwin Sidik, J
Depletion of Gr-1+ neutrophils by systemic anti-Gr-1 treatment prevents exacerbated neurodegeneration in RAG1-KO mice. Depletion of Gr-1+ neutrophils by.
Amino acid residues in the PD-L1 IgV domain involved in PD-1 and/or B7-1 binding. Amino acid residues in the PD-L1 IgV domain involved in PD-1 and/or B7-1.
Volume 45, Issue 3, Pages (February 2005)
Fig. 2 Induction and waning kinetics of merozoite-specific IgM during naturally acquired P. falciparum malaria. Induction and waning kinetics of merozoite-specific.
Presentation transcript:

Affinity of human IgG subclasses to mouse Fc gamma Receptors Supplementary figures and tables for: Affinity of human IgG subclasses to mouse Fc gamma Receptors Gillian Dekkers, Arthur E.H. Bentlage, Tamara C. Stegmann, Heather L. Howie, Suzanne Lissenberg- Thunnissen, James Zimring, Theo Rispens and Gestur Vidarsson

Dekkers et al. supplementary Figure 1 Supplementary Fig. 1 Sensorgram of mouse IgG subclasses binding to mouse FcγR Each mouse IgG subclasses in concentration ranges from 3.9 nM to 1140 nM flown over different spotted mouse FcγR, only the sensorgrams for the highest ligand concentration of the different mouse FcγR are shown; FcgRI 30nM, mFcgRIIb 100nM, FcgRIII 100nM and mFcgIV 30nM.

Dekkers et al. Supplementary Figure 2 Supplementary Fig. 2 Sensorgram of human IgG subclasses binding to mouse FcγR Each human IgG subclasses in concentration ranges from 1.5 nM to 3000 nM for human IgG1 and IgG3, from 15.6 nM to 2000 nM for human IgG2, or from 23.4 nM to 3000 nM for human IgG4, flown over different spotted mouse FcγR, only the sensorgrams for the highest ligand concentration of the different mouse FcγR are shown; FcgRI 30nM, mFcgRIIb 100nM, FcgRIII 100nM and mFcgIV 30nM.

Dekkers et al. Supplementary Figure 3 Supplementary Fig. 3 Binding of human IgG subclasses to mouse FcγR The human IgG1, IgG2 and IgG3 anti-pneumococcal (Gdob1) and IgG4 anti birch antigen (BetV1) were assessed for their binding affinity in KD (M) to the mouse FcγRI, FcγRIIb, FcγRIII and FcγRIV by SPR. -/- denotes no binding detected, * denotes binding > 3 μM, represented by the horizontal dashed line which indicates the maximum concentration of IgG which is used. Data represents means and SEM of n=2.

Dekkers et al. Supplementary Figure 4   Anti-RhD hIgG1 Anti-RhD hIgG2 Anti-RhD hIgG3 Anti-RhD hIgG4 FcγRI 5.2x10-9 -/- 4.5x10-9 7.0x10-9 FcγRIIa131H 9.8x10-8 1.0x10-7 1.9x10-7 1.9x10-6 FcγRIIa131R 6.8x10-8 4.9x10-7 1.7x10-7 3.9x10-7 FcγRIIb 1.3x10-7  * 5.9x10-7 3.1x10-7 FcγRIIIa158F 4.3x10-7 1.1x10-6 *  FcγRIIIa158V FcγRIIIb NA1 2.7x10-7 8.7x10-7 FcγRIIIb NA2 7.4x10-7 b Supplementary Fig. 4 Affinity of human IgG subclasses to human FcγR a, b) Affinity in KD (M) of human anti-RhD IgG subclasses to human FcγR family. -/- denotes no binding detected, * denotes binding > 2μM, represented by the horizontal dashed line which indicates the maximum concentration of IgG which is used. Data is single representative of n=3.

Dekkers et al. Supplementary Table 1 Comparison of affinity in KD (μM) of mouse IgG subclasses for mouse FcγRs from this research versus literature. Data obtained in this research in bold type, S.E.M. in brackets behind KD, -/- no binding detected. mFcγRI mFcγRIIb mFcγRIII mFcγRIV mIgG1 -/- 0.15 (0.05) 0.23 (0.03) -/- S1 0.30 S1 3.2 S1 -/- S2 0.83 S2 4.8 S2 -/- S3 0.17 S3 0.32 S3 0.25 S4 2.0 S4 -/- S4 mIgG2a 0.012 (0.002) 0.69 (0.16) 0.34 (0.04) 0.060 (0.020) 0.006 S1 2.4 S1 1.5 S1 0.035 S1 0.026 S2 1.8 S2 0.071 S2 0.018 S3 0.14 S3 0.010 S3 0.033 S5, a 0.022 S6, b 0.0013 S6, c mIgG2b 0.83 (0.14) 0.45 (0.06) 0.12 (0.03) -/- S7 0.45 S1 1.6 S1 0.059 S1 0.91 S2 1.6 S2 0.063 S2 0.26 S4 0.91 S4 0.034 S4 10 S5, a -/- S6, b 0.021 S6, c mIgG3 0.011 S6, c a, As provided in the review of Bruhns and Jönsson S5, original source unknown. b, Affinity for Fc RI.1 (a) allele, as described by Gavin et al. S6. c, Affinity for Fc RI.4 (d) allele, as described by Gavin et al. S6. References: S1. Nimmerjahn F, Bruhns P, Horiuchi K, Ravetch J V. FcyRIV: A novel FcR with distinct IgG subclass specificity. Immunity 2005; 23:41–51. S2. Baudino L, Nimmerjahn F, Shinohara Y, Furukawa J-I, Petry F, Verbeek JS, Nishimura S-I, Ravetch J V, Izui S. Impact of a three amino acid deletion in the CH2 domain of murine IgG1 on Fc-associated effector functions. J Immunol 2008; 181:4107–12. S3. White AL, Chan HTC, Roghanian A, French RR, Mockridge CI, Tutt AL, Dixon S V, Ajona D, Verbeek JS, Al-Shamkhani A, et al. Interaction with FcγRIIB is critical for the agonistic activity of anti-CD40 monoclonal antibody. J Immunol 2011; 187:1754–63. S4. Kaneko Y, Nimmerjahn F, Ravetch J V. Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science 2006; 313:670–3. S5. Bruhns P, Jönsson F. Mouse and human FcR effector functions. Immunol Rev 2015; 268:25–51. S6. Gavin AL, Leiter EH, Hogarth PM. Mouse FcgammaRI: identification and functional characterization of five new alleles. Immunogenetics 2000; 51:206–11. S7. Nimmerjahn F, Ravetch J V. Divergent immunoglobulin g subclass activity through selective Fc receptor binding. Science 2005; 310:1510–2.